Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...

A local health company struggles to pay its bills after a failed $320 million deal, an exclusive event series returns to a historic Baltimore home, and more in today's newsletter.